Healthcare provider profile · identity verified

Amir Obbehat, M.D.

Internal Medicine · ALAMOSA, CO · NPI 1346555984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	670	224
Levothyroxine Sodium	Levothyroxine Sodium	476	137
Amlodipine Besylate	Amlodipine Besylate	380	128
Lisinopril	Lisinopril	370	122
Losartan Potassium	Losartan Potassium	300	107
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	275	60
Tamsulosin Hcl	Tamsulosin Hcl	268	92
Hydrochlorothiazide	Hydrochlorothiazide	214	77
Albuterol Sulfate Hfa	Albuterol Sulfate	169	76
Simvastatin	Simvastatin	163	51
Pantoprazole Sodium	Pantoprazole Sodium	158	57
Metoprolol Tartrate	Metoprolol Tartrate	147	46
Omeprazole	Omeprazole	147	50
Metoprolol Succinate	Metoprolol Succinate	146	57
Gabapentin	Gabapentin	140	57
Metformin Hcl Er	Metformin Hcl	133	46
Metformin Hcl	Metformin Hcl	124	40
Trazodone Hcl	Trazodone Hcl	116	41
Alendronate Sodium	Alendronate Sodium	104	32
Famotidine	Famotidine	101	36
Fluticasone Propionate	Fluticasone Propionate	101	36
Prednisone	Prednisone	98	75
Rosuvastatin Calcium	Rosuvastatin Calcium	97	35
Furosemide	Furosemide	96	41
Allopurinol	Allopurinol	95	29
Atenolol	Atenolol	94	31
Tramadol Hcl	Tramadol Hcl	94	34
Ibuprofen	Ibuprofen	90	33
Meloxicam	Meloxicam	88	34
Citalopram Hbr	Citalopram Hydrobromide	81	28
Wixela Inhub	Fluticasone Propion/Salmeterol	80	22
Escitalopram Oxalate	Escitalopram Oxalate	73	33
Hydralazine Hcl	Hydralazine Hcl	73	24
Fluoxetine Hcl	Fluoxetine Hcl	72	24
Lovastatin	Lovastatin	69	20
Ozempic	Semaglutide	66	suppressed
Sertraline Hcl	Sertraline Hcl	63	20
Pradaxa	Dabigatran Etexilate Mesylate	62	21
Zolpidem Tartrate	Zolpidem Tartrate	61	12
Alvesco	Ciclesonide	60	23
Triamcinolone Acetonide	Triamcinolone Acetonide	60	26
Glipizide	Glipizide	57	18
Montelukast Sodium	Montelukast Sodium	57	18
Terazosin Hcl	Terazosin Hcl	56	15
Breyna	Budesonide/Formoterol Fumarate	54	18
Propranolol Hcl	Propranolol Hcl	53	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	14
Lorazepam	Lorazepam	49	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	43
Jardiance	Empagliflozin	46	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	45	15
Oxycodone Hcl	Oxycodone Hcl	45	11
Potassium Chloride	Potassium Chloride	45	17
Hydrocortisone	Hydrocortisone	44	23
Donepezil Hcl	Donepezil Hcl	43	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	16
Ropinirole Hcl	Ropinirole Hcl	43	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	40
Clopidogrel	Clopidogrel Bisulfate	39	13
Spiriva Respimat	Tiotropium Bromide	39	13
Eliquis	Apixaban	38	13
Ondansetron Hcl	Ondansetron Hcl	38	13
Warfarin Sodium	Warfarin Sodium	38	12
Pravastatin Sodium	Pravastatin Sodium	37	14
Duloxetine Hcl	Duloxetine Hcl	36	15
Spironolactone	Spironolactone	36	16
Tizanidine Hcl	Tizanidine Hcl	35	17
Carvedilol	Carvedilol	34	14
Diazepam	Diazepam	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	34	31
Glipizide Er	Glipizide	34	12
Acyclovir	Acyclovir	33	14
Finasteride	Finasteride	33	11
Mirtazapine	Mirtazapine	32	11
Bupropion Xl	Bupropion Hcl	31	11
Ipratropium Bromide	Ipratropium Bromide	30	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Naproxen	Naproxen	30	14
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Nystatin	Nystatin	28	17
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Azithromycin	Azithromycin	25	22
Pregabalin	Pregabalin	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	24	suppressed
Primidone	Primidone	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Alprazolam	Alprazolam	22	11
Baclofen	Baclofen	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	14
Retin-A	Tretinoin	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Topiramate	Topiramate	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Metronidazole	Metronidazole	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Humulin N	Insulin Nph Human Isophane	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Cephalexin	Cephalexin	16	15
Colchicine	Colchicine	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Denta 5000 Plus	Fluoride (Sodium)	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	11	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error